Novel Combo Promising in Advanced HER2-Negative Breast Cancer

(MedPage Today) -- At the European Society for Medical Oncology (ESMO) virtual meeting, researchers presented the results of a study evaluating the combination of entinostat, nivolumab (Opdivo), and ipilimumab (Yervoy) in patients with advanced...